drugset / Trial / NCT06578949
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Ravulizumab in Chinese Adults Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the efficacy of ravulizumab in adult participants with PNH.
Timeline
- Start
- 2024-10-10
- Primary completion
- 2025-05-15
- Completion
- 2025-12-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ravulizumab | Monoclonal antibody | — | Intravenous |